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THE EFFECT OF PHOSPHATE DEFICIENCY ON BMP-2 TREATED 
C3H10T1/2 MESENCHYMAL STEM CELLS 
MATTHEW DAVID BUI 
ABSTRACT 
There are approximately 600,000 cases of delayed or aberrant fracture healing in 
people each year, with a small subset of these fractures experiencing disunion. Dietary 
phosphate deficiency has been shown to impair oxidative phosphorylation and decrease 
BMP-2 mediated chondrogenic differentiation during fracture healing. Prior studies using 
pre-committed chondro-progenitor ATDC5 cell line grown in phosphate deficient media 
showed that energy consumption was linked to protein production and collagen 
hydroxylation but inversely related to matrix mineralization. The goal of this study was to 
further define the relationship between energy consumption and BMP-2 mediated stem 
cell chondrogenic differentiation and further examine how dietary phosphate, and 
promotion of collagen hydroxylation via ascorbate availability effected these processes. 
C3H10T1/2 murine cells, a multi-potential cell line, were expanded in pre-
differentiation growth medium (DMEM with 10% FBS and 1% Pen/Strep). Once cells 
reached 60% confluence (day 0), they were grown in differentiating media (α-MEM with 
5% FBS and 1X insulin-transferrin-selenium) containing either 100% (1mM) or 25% 
(0.25mM) inorganic phosphate (Pi), ± 200ng/mL BMP-2(BMP), and ±0.2 mM L-
ascorbic acid (AA). In total, there were 8 groups with varying combinations of these three 
substances. Intracellular lipid, total DNA, protein, and hydroxyproline (HP) content were 
examined. Chondrocyte gene expression (Col2a1, Acan, ColXa1) and adipocyte gene 
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expression (Pparg, Plin1, Ucp1) were measured to check for cell lineage commitment 
and specific differentiation of the C3H10T1/2. All measurements were acquired at day 8. 
The +BMP differentiation media groups contained significantly less DNA content 
and more protein content than the –BMP differentiation media groups (both p<0.0001). 
There was also a significant interaction between phosphate and ascorbic acid treatment 
(p=0.0296), with 25% Pi +AA groups producing significantly more protein than 100% Pi 
+AA groups. Hydroxyproline production was not different in 100% Pi or 25% Pi 
conditions (p=0.2951). AA presence in culture media led to greater HP production than 
culture media lacking AA (p=0.0035) There was a trend of an interaction between 
phosphate content and AA availability (p=0.0744). 100% Pi ±AA groups produced 
significantly different amounts of HP while 25% Pi ±AA groups did not produce 
significantly different amount of HP. Col2a1, Acan, and ColXa1 expression were all 
increased in +BMP groups. Ascorbic acid treatment groups expressed significantly more 
Col2a1and Acan than –AA groups. 100% Pi media led to greater Acan expression over 
25% Pi groups (p=0.0009), whereas 25% Pi media trended to lead to greater ColXa1 
expression over 100% Pi groups (p=0.0734). Pparg and Plin1 expression were increased 
in the 25% Pi condition. There were no significant differences in expression of Ucp1. 
C3H10T1/2 cells were significantly affected by phosphate concentration, BMP-2 
treatment, and ascorbic acid supplementation. Phosphate deficiency hindered maturation 
of early chondrocytes into proliferating chondrocytes while also promoting MSC 
differentiation into the adipocyte cell lineage. Hypertrophic chondrocyte expression was 
decreased in phosphate deficient media, which may coincide with increased protein 
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production observed in low phosphate conditions. BMP-2 promoted chondrogenesis 
which resulted in increased protein production. Whereas, lack of ascorbic acid in cell 
culture media led to decreased hydroxyproline production. 
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INTRODUCTION 
 Bone is a specialized connective tissue that provides the human body with 
structural support and stability while also housing the site of blood cell development 
(Mescher 2016). Bone is comprised of organic type I collagen fibers which are 
strengthened by mineralization with inorganic hydroxyapatite, (Ca10(PO4)6(OH)2). This 
mineral underlies the important role that bone plays in homeostasis of both calcium and 
phosphate as it is the primary storage site for these elements (Mescher 2016). When 
bones are submitted to forces greater than they can structurally handle, a fracture occurs. 
There are approximately 7.9 million fractures that occur each year, with many healing 
properly; however, it is estimated that 600,000 of these fractures have delayed or 
abnormal healing (Buza and Einhorn 2016). When a fractured bone has not completely 
healed in nine months following the initial injury and exhibits no progression of healing 
with three months of serial radiographs, as is outlined by the Federal Drug 
Administration (FDA), the fracture is then classified as nonunion (Bishop et al. 2012). 
This occurs in approximately 100,000 fractures each year and requires expensive and 
time-consuming therapy (Bishop et al. 2012). While there are many factors that can 
contribute to delayed fracture healing and nonunion, this study will attempt to elucidate 
the role that phosphate deficiency has on the developmentally similar process of 
endochondral ossification in fracture healing. As phosphate is a vital component to the 
inorganic component of bone as well as other biochemical components including cell 
energy metabolism, this study will identify the impact of phosphate deficiency from the 
point of mesenchymal stem cell condensation and initial differentiation. 
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1. Bone Development 
1.1 Mesenchymal Stem Cells 
 Mesenchymal stem cells (MSCs) are multipotent cells that have the ability to 
differentiate and develop into many cell types including osteoblasts, myocytes, 
chondrocytes, and adipocytes (Caplan 1991). These cells are found in various locations 
including adipose tissue, bone periosteum, muscle, and bone endosteum (De Bari et al. 
2006; Gharaibeh et al. 2008; Zuk et al. 2002).The MSCs are attractive for in vitro studies 
due their ability to self-renew into multipotent cells, their capability to divide into 
multiple cell types, and their ability to be influenced by different biological and 
pharmacological agents.  
 MSCs play an active role in fetal development and specifically initiate the process 
of in utero bone development when they invade the site of the future bone. MSCs must 
contact the basement membrane of nearby epithelial cells which then causes these cells to 
cluster into condensations (Hall and Miyake 2000). After condensations, there are two 
possible pathways that the cells could take in order to differentiate and develop into bone: 
intramembranous ossification and endochondral ossification. 
1.2 Intramembranous Ossification 
In the first possible process of osteogenesis, intramembranous ossification, the cell 
condensations are surrounded by vasculature which will sprout into the condensations 
(Percival and Richtsmeier 2013). After the invasion of the blood vessels in to the 
condensations, the MSCs then differentiate into osteoprogenitors and subsequently into 
osteoblasts, as indicated by the activation of the transcription factor Runx2 (Ducy et al. 
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1997). The mature osteoblasts then produce and secrete unmineralized collagen, which is 
later mineralized to directly develop bone. This method of bone growth, however, is only 
seen in a small number of bones consisting mainly of flat bones in the face and skull, the 
mandible, and the clavicle. 
 
1.3 Endochondral Ossification 
The second process of bone development, which is utilized for making the 
majority of bones in the body including limb bones and the axial skeleton, is 
endochondral ossification. After the MSCs coalesce and condense, they will then 
differentiate into early chondrocytes, which is regulated by the transcription factor Sox9 
(Akiyama et al. 2005). In the developing long bones, chondrocytes are oriented in 
different zones of resting, proliferation, hypertrophy, and calcification (Figure 1). The 
early chondrocytes begin to express the genes Aggrecan and Col2a1 as they begin to 
synthesize the proteins aggrecan and type II collagen for extracellular matrix deposition 
(Long and Ornitz 2013). These cells are a part of the proliferating zone due to their 
increased dissemination that accompany their secretion of extracellular matrix proteins. 
The chondrocytes then start to express Col10a1 and produce type X collagen as they 
express less Col2a1 and produce less type II collagen in what becomes known as the 
hypertrophic zone (Long and Ornitz 2013). The hypertrophic chondrocytes are also 
responsible for extracellular matrix mineralization, thus producing calcified cartilage. At 
this point, hypertrophic chondrocytes undergo either cell death or differentiation into the 
osteoblast lineage (Tsang, Chan, and Cheah 2015). Ultimately, chondroclasts help to 
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resorb the calcified cartilage with osteoblasts infiltrating these areas and forming 
secondary bone (Ortega, Behonick, and Werb 2004). 
 
Figure 1. Zones of Chondrocytes During Endochondral Ossification. Early 
chondrocytes expressing Col2a1 and Acan are located in the Zone of Reserve Cartilage 
(Resting) and Zone of Proliferation. Chondrocytes expressing Col10a1 are located in the 
Zone of Hypertrophy. These chondrocytes contribute to matrix mineralization and 
ultimately are replaced by osteoblasts which form new bone. (From Jennings and 
Premanandan, 2016) 
 
 
2. Mesenchymal Stem Cells and Fracture Healing 
 Fracture healing is a coordinated process in which multiple cell types are recruited 
to the site of the injury to heal the injured bone tissue. During fracture healing, there are 
four distinct yet concurrent phases occurring: inflammation, intramembranous 
ossification, endochondral ossification, and bone remodeling (Figure 2). In development, 
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intramembranous ossification and endochondral ossification are utilized as separate 
entities for different bones, however both are employed during fracture healing; their 
locations differ, though, as the former is only employed on the distal ends of the fracture 
and the latter is used in the gap site between the ends (Marsell and Einhorn 2011).  When 
a fracture occurs, the immediate effect is bleeding and the development of a hematoma at 
the site of fracture. This hematoma is full of cytokines which cause the recruitment and 
migration of inflammatory cells to the injury. MSCs are recruited, however the 
mechanism of this and the precise molecular events that precede their arrival are poorly 
understood. The source of these MSCs is under debate, but current research points to the 
periosteum, endosteum, bone marrow, and possibly circulating blood as sites of origin 
(Gerstenfeld et al. 2003). 
It is not until after MSCs migrate from their original site of origin to the site of 
injury that they will differentiate. Normal MSC differentiation into either osteoblasts, as 
seen in intramembranous ossification, or chondrocytes, as seen in endochondral 
ossification, is influenced by multiple factors. First, it has been shown that in sites where 
there is less fracture stability, as is the case in the gaps or center of the fractures, there 
will be heightened preference to differentiate into chondrocytes (Morgan et al. 2010). 
Second, there are multiple signaling factors such as the bone-morphogenetic protein 
(BMP) family, parathyroid hormone, and transforming growth factor  (TGF-β) that 
regulate bone healing and MSC differentiation (Bais et al. 2009). Last, vascularization, 
and more specifically oxygenation, is a critical determinant of MSC differentiation. In 
regions of low oxygenation, there is a preference for MSCs to differentiate into 
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chondrocytes and in regions of high oxygenation, there is a preference for MSCs to 
differentiate directly into osteoblasts (Schipani 2006). Once MSCs have begun to 
differentiate into cartilage in the fracture gap, the chondrocytes form a soft cartilage 
callus that acts as a temporary scaffold between the broken bone ends (Phillips 2005).  
After the MSCs have differentiated, the endochondral phase of fracture healing 
begins. During this phase, the soft cartilage callus composed of chondrocytes is replaced 
by osteoblasts and eventually new calcified bone. Just as in normal endochondral 
ossification as stated above, the mechanism of replacement of the chondrocytes by 
osteoblast is still precisely unknown. Once the new bone has been laid down, the last 
stage of fracture healing relies on the transition of woven immature bone to mature 
cortical bone via bone remodeling. 
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Figure 2. Timing and cell recruitment of the inflammatory, endochondral, and bone 
remodeling stages of fracture healing. In the inflammatory stage, many types of 
inflammatory cells are initially present followed by the recruitment of MSCs. In the 
fracture gap, MSCs differentiate into chondrocytes which develop the soft callus. The 
soft callus then becomes mineralized and is ultimately replaced by osteoblasts which 
make new bone. (From Einhorn and Gerstenfeld, 2014.) 
 
3. Phosphate Deficiency and Its Role in Bone and Cartilage Development 
 Phosphate is an essential element in many processes in the body, including but not 
limited to, acid and base balance through buffering, energy development and utilization, 
nucleotide structure, and proper bone development. Inherited and acquired conditions of 
phosphate metabolism disorders, such as rickets and osteomalacia, exhibit bone fragility, 
poor bone growth, impaired fracture healing, and abnormal mineralization (Hutchison 
and Bell 1992). All of the different subcategories of these conditions are 
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hypophosphatemic in nature and this phosphate-deficient state has direct implications in 
the underlying abnormal regulation of bone health.  
 
3.1 Phosphate Deficiency’s Role in Chondrocyte Differentiation 
In children with hypophosphatemic rickets, stunted growth is attributed to 
abnormalities in the growth plate including improper elongation and lack of 
mineralization(Sugita et al. 2011). During normal endochondral ossification, the 
differentiation of chondrocytes in the various zones of maturation follows in parallel with 
increasing phosphate concentration (Denison et al. 2009). In the late hypertrophic zone, 
terminally differentiated hypertrophic chondrocytes undergo apoptosis in order to allow 
for matrix mineralization and vascular infiltration (Sabbagh, Carpenter, and Demay 
2005). This cell-specific, caspase-mediated apoptosis in the growth plate is mediated by 
phosphate which activates mitochondrial permeability transition (Sabbagh, Carpenter, 
and Demay 2005). When there is a lack of phosphate, as seen in the hypophosphatemic 
conditions noted above, this caspase-mediated apoptotic process in hypertrophic 
chondrocytes is impaired and in rickets this leads to the hallmark abnormal elongation of 
the growth plate (Sabbagh, Carpenter, and Demay 2005). Not only is the impairment of 
differentiation of chondrocytes in the hypertrophic phase via apoptosis shown to be 
influenced by phosphate deficiency, but also it has been shown that phosphate restriction 
impairs differentiation of proliferative chondrocytes into hypertrophic chondrocytes (Liu 
et al. 2014). 
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3.2 Phosphate Deficiency’s Role on MSC Commitment and Differentiation 
It is known that MSCs can commonly differentiate into chondrocytes, osteoblasts, 
and adipocytes (Pittenger et al. 1999). In multiple studies looking at phosphate’s role into 
cell development and differentiation they show that cells of non-skeletal tissues, 
specifically human vascular smooth muscle cells, are induced by phosphate to change the 
cells to osteogenic-like cells (Jono et al. 2000; Giachelli et al. 2001). Further, it has been 
elucidated that phosphate is imperative in the differentiation of human MSCs into 
osteoblasts by regulating intramitochondrial phosphate levels as well as ATP synthesis 
(Shih et al. 2014). Both of these findings give credence to the assumption that phosphate 
can play a major role in intramembranous ossification, possibly indicating that that there 
can be an implication for fracture healing along the endosteal surfaces and fracture edge.  
At this point, there have been limited studies on the specific role of phosphate in 
intramembranous fracture healing. However, a group of investigators that administered 
phosphate-deficient diets in developing mice noticed that early markers of MSC 
differentiation into osteoblasts including Sox9 and late markers of MSC differentiation 
into osteoblasts including Osterix and Osteocalcin were upregulated and downregulated, 
respectively (Ko et al. 2016). This study also showed that along with decreased bone in 
phosphate-deficient mice, there was also increased adipocyte differentiation markers, 
suggesting that phosphate deficiency not only arrested MSC differentiation towards 
mature osteoblasts, but also that it promoted adipocyte growth at the same time (Ko et al. 
2016). Even more so, another study that focused on phosphate restriction diets in mice 
presents findings that indicate that osteocalcin expression was not different in fractures of 
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phosphate-deficient and control diet mice (Wigner et al. 2010). These two findings 
provide an unclear picture of the exact role of phosphate in intramembranous bone 
growth at the level of MSC differentiation.  
While there is still limited information on the role of phosphate deficiency on 
MSC osteogenesis via intramembranous growth, there is even less information available 
of its role in MSC commitment to the chondrocyte lineage as a model of endochondral 
ossification. One in vivo study has investigated the role of phosphate-deficient diets on 
chondrocyte differentiation in fracture models in mice (Wigner et al. 2010). It was shown 
that while early markers of MSC commitment to the chondrocyte lineage were increased 
in phosphate-deficient diet fractures, expression levels of markers for the progression of 
chondrocyte differentiation, aggrecan and MMP13, markers of chondrocytes, were 
diminished compared to control diet groups (Wigner et al. 2010). 
 
4. Bone Morphogenetic Protein-2 
 The bone morphogenetic proteins (BMPs) are a subgroup of over 20 growth 
factors in the Transforming Growth Factor Beta (TGF-β) superfamily (Bragdon et al. 
2011). These proteins have a significant role in developmental processes and limb 
patterning (Bandyopadhyay et al. 2006). One of these BMPs, bone morphogenetic 
protein-2 (BMP-2), has been shown to cause ectopic bone formation and have a critical 
role in bone development (Wozney et al. 1988). BMP-2 also is a key player in skeletal 
fracture healing and is a necessity for the earliest stage of fracture repair as it is one of the 
first major growth factors expressed after a fracture (Cho, Gerstenfeld, and Einhorn 
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2002). This expression of BMP-2 after a fracture is continually expressed throughout 
three weeks of the fracture repair (Cho, Gerstenfeld, and Einhorn 2002).  
 
4.1 BMP-2’s Role in Fracture Healing 
Early BMP-2 expression was originally thought to be an important factor in the 
recruitment of MSCs during fracture healing, however studies showed that this is not the 
case (Bais et al., 2009). Instead, the importance of BMP-2 during early fracture healing 
has been thought to include its ability to signal for the expression of other bone 
morphogenetic proteins, including BMP-3 and BMP-4 (Cho, Gerstenfeld, and Einhorn 
2002). More importantly, though, BMP-2’s action during the early stage of fracture 
healing is related to the differentiation of the MSCs that are recruited to the site of injury 
(Tsuji et al. 2006). In molecular analysis of tissues harvested from fractures in Bmp2 
mutant mice, lack of chondrogenensis was observed in the fracture site as MSCs 
remained in their undifferentiated state (Tsuji et al. 2006). These MSCs actually had 
increased BMP receptors, representing that they were ready to differentiate, but lacked 
the proper stimuli necessary to do so (Tsuji et al. 2006). This lack of differentiation is 
reasonable to explain why no cartilage, and hence no bone was grown in these BMP-2 
deficient mice fractures. 
Additionally, there have been many in vitro studies that replicate the sentiment 
that BMP-2 is an important factor in MSC differentiation. Wang et al. studied 
C3H10T1/2 MSC differentiation into fat, cartilage, and bone cells in the presence of 
BMP-2 and noted that the differentiation of the MSCs into different cell types was 
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dependent on the BMP-2 concentrations, with high concentrations promoting 
chondrogenesis and osteogenesis and low concentrations promoting adipogenesis (Wang 
et al. 1993). This result was confirmed by another in vitro study looking at both BMP-7 
and BMP-2 that will direct chondrogenic differentiation in these cells (Shea et al. 2003).  
 
5. Ascorbic Acid and Its Role in Differentiation and Collagen Production 
Ascorbic acid (AA), or vitamin C, plays a key role in the maintenance of bone, 
cartilage, and other specialized connective tissues. One of the most important functions 
that AA has is its relationship with the collagen proteins, thus having a profound impact 
on integrity of extracellular matrix (ECM). AA has a role in the synthesis of procollagen 
by promoting transcription of procollagen genes or stabilizing the resulting mRNA 
(D’Aniello et al. 2017). Not only is AA necessary for initial transcription, but AA is also 
a necessary co-factor in the post-translational modification of procollagen molecules 
during proline hydroxylation. In this enzymatic reaction, proline amino acids located 
within the procollagen molecule are hydroxylated by the enzyme prolyl-4-hydroxylase 
(Figure 3). This enzyme requires AA and iron as necessary co-factors and if AA is not 
present, this leads to collagen instability as seen in the condition of scurvy (Gorres and 
Raines 2010). As collagen is the main organic component of bone, AA deficiency has an 
important impact of bone formation and remodeling.  
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Figure 3. Hydroxylation of Proline Reaction. This reaction is one of the main post-
translational modifications of collagen which provides the molecule with stability in 
order for individual collagen molecules to cross-link. One molecule of ascorbate is used 
for every -OH (in red) that replaces a hydrogen. Not pictured is the necessary Fe2+ 
cofactor. (From Sahni et al., 2010) 
 
Ascorbic acid also has other roles in osteogenesis. With regards to stem cell 
populations, the production of collagen in ECM promoted by AA helps to fine tune and 
promote cell proliferation, differentiation, and self-renewal (D’Aniello et al. 2017). 
Specifically, it was seen in pre-osteoblasts that these actions are thought to be caused by 
collagen and integrin interactions of the surface of the cells (Carinci et al. 2005). It was 
also seen that AA has a role in fracture healing as in mice with AA deficient diets had 
less differentiation toward the bone lineage and more differentiation toward the adipocyte 
lineage (Park et al. 2012).  
 
6. Motivation 
A recent study has shown that in three inbred strains of mice, A/J (AJ), C57BL/6J 
(B6), and C3H/HeJ (C3), administered a phosphate-deficient diet show delayed and 
impaired fracture healing (Wulff et al. 2015). A further transcriptomic analysis of the 
fracture calluses from these mice exhibited significant down regulation of mitochondrial 
oxidative phosphorylation, indicating oxidative phosphorylation dysfunction (Figure 4). 
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These findings indicate that diminished phosphate conditions have implications in normal 
oxidative phosphorylation during fracture healing.   
 
Figure 4. Top canonical pathways affected by low-phosphate diets in mice fracture 
calluses. Mice were given either a normal phosphate or phosphate-deficient diet and 
closed stabilized femoral fractures were induced. Calluses from the fractures were 
harvested at multiple time points between 3 and 35 days post-fracture. Total RNA was 
isolated from the calluses and gene expression was analyzed using microarray. Mice 
given a phosphate deficient diet demonstrated changes in gene expression consistent with 
dysfunction of the oxidative phosphorylation pathway. (From Hussein, et al. 2017)  
 
Another in vivo study assessing bones of developing mice fed a phosphate-
deficient diet showed that bone development was impeded as there was less bone and 
more marrow adipose tissue present (Ko et al. 2016). This increased presence of adipose 
tissue was thought to be due to a shift of MSC commitment to the adipocyte lineage in 
low phosphate conditions. Another group examined in vivo data on the effect of low-
phosphate diets on fracture healing and observed that there was decreased downstream 
BMP-2 signaling, possibly indicating that low phosphate conditions lead to impaired 
chondrogenic differentiation of MSCs due to BMP-2 resistance (Wigner et al. 2010).  
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Lastly, a recent study of ATDC5 chondro-progenitor cells looked at the role of 
inorganic phosphate and organic phosphate availability on cell metabolism, protein 
production, and matrix mineralization during differentiation (Blank 2016). It was noted 
that organic phosphate in the form of β-glycerol phosphate was necessary for ECM 
mineralization. When analyzing metabolic consumption, it was seen that differentiation 
of the chonrdro-progenitors coincided with an increase in energy consumption (Blank 
2016). It was also of note that in conditions with severe inorganic phosphate restriction, 
there was increased protein production as well as increased oxygen consumption (Blank 
2016). All of these studies provide insight that there may be a link between phosphate 
deficiency and MSC differentiation as well as an interplay between phosphate deficiency 
and BMP-2 signaling that may impair the differentiation of MSCs. Not only that, but 
there might be implications of phosphate deficiency in MSC metabolism and lineage 
commitment that have yet to be elucidated. 
 
7. Study Goals 
This study examined the role of phosphate availability in combination with BMP-
2 and ascorbic acid availability on the differentiation, commitment, collagen production, 
and metabolic function of the multi-potentiation murine C3H10T1/2 embryonic stem cell 
line. The goal of this study was to elucidate the role that low phosphate conditions play in 
BMP-2 signaling during MSC cell lineage commitment and differentiation. This study 
further compared the results with this cell line to the ATDC chondro-progenitors that we 
previously had shown to have increased energy consumption during differentiation and 
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will try to understand different conditions and possible causative factors for this energy 
intensive process. These studies further are directed at how hydroxylation of collagen 
effects these processes. In this context, we hypothesize the synthesis of hydroxyproline is 
the energy intensive process. It was seen in microarray analysis of the fracture mice that 
expression of 4-prolyl-hydroxylase subunits are downregulated in restricted phosphate 
conditions (Carroll 2016). As the hydroxylation of proline shares a common substrate 
with the TCA cycle (Figure 5), this study will try to manipulate the hydroxylation of 
proline by introducing an ascorbate deficiency and observe what cellular energetic 
changes, if any, occur during MSC differentiation in phosphate deficient or normal 
phosphate conditions. 
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Figure 5. Interplay between the Hydroxylation of Proline and the TCA Cycle. Both 
processes share the common substrate of α-Ketoglutarate. The green arrows show the 
substrate and products of the hydroxylation of proline by the enzyme 4-prolyl 
hydroxylase (P4H). (From Theodosiou et al., 2015) 
 
8. Specific Aims 
The goals of this study were: 
1. To assess the role of phosphate and BMP-2 availability on MSC differentiation 
and cell lineage commitment; and 
2. To determine the effect of phosphate, BMP-2, and ascorbate availability on 
protein and collagen production in differentiating MSCs. 
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METHODS 
1. Cell Culture 
C3H10T1/2 murine stem cell line was used for all studies. These cells were provided 
at passage 13 by Dr. Stephen Farmer’s Laboratory in the Boston University School of 
Medicine’s Biochemistry Department. C3H10T1/2 cells were expanded in a pre-
differentiation growth medium consisting of Dulbecco’s Modified Eagle Medium 
(DMEM) (Thermo Fisher Scientific, Waltham, MA) with 10% fetal bovine serum 
(Atlanta Biologicals, Inc., Flowery Branch, GA) and 1% penicillin/streptomycin 
antibiotic (Thermo Fisher Scientific, Waltham, MA) in a humidified incubator (37° C, 
5% CO2). For the experiments on protein, hydroxyproline, and intracellular lipid 
accumulation, cells were seeded on 12 well cell culture plates (Corning Inc., Corning, 
NY) at a density of 1.5 x 104 cells per well. For RNA extraction, cells were seeded on 6 
well cell culture plates (Corning Inc., Corning, NY) at a density of 4.0 x 104 cells per 
well. For all experiments, after the cells were seeded on their respective cell culture 
plates, they were incubated for 2-3 days in pre-differentiation growth medium to reach 
approximately 60% confluence. When this level of confluence was reached, the cell 
culture medium was changed to one of three types: control growth medium, 100% Pi 
medium, and 25% Pi medium (see Table 1). Experimental groups containing 100% 
(1mM) Pi and 25% (0.25mM) Pi medias were induced to differentiate by 
supplementation with 1X insulin-transferrin-selenium (Lonza Walkersville Inc., 
Walkersville, MD). To examine the effects of ascorbic acid and BMP-2, groups were 
treated with ± 200 ng/mL BMP-2 (Research and Diagnostic Systems, Inc., Minneapolis, 
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MN) and ± 0.2mM L-Ascorbic Acid (Sigma-Aldrich Corporation, St. Louis, MO). In 
total, eight experimental groups were established with varying combinations of BMP-2, 
L-Ascorbic Acid, and phosphate levels (see Table 2). The cells were fed with media 
every two days, with BMP-2, L-Ascorbic Acid, and 1X insulin-transferrin-selenium 
being prepared immediately before the media change. At day 8, cell materials were 
extracted and collected and subsequent experiments were performed. A pilot study was 
performed to determine key timepoints to measure gene expression. Analysis of this 
parameter was performed at days 4 and 8 post induction of differentiation media. At the 
conclusion of the preliminary data collection and analysis, it was determined there was 
high variability at day 4, and thus day 8 was chosen for this study. All experiments were 
run twice to prove reproducibility. 
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Table 1. Culture Medium Conditions. All culture medium conditions were 
supplemented with 1% penicillin/streptomycin antibiotic. Medias were provided with 
different levels of media base, bovine supplements, differentiating supplements, ascorbic 
acid, BMP-2, and phosphate. 
 Medium Name 
 Expansion Control Growth 100% Pi 25% Pi 
Base DMEM1 α-MEM1 
Custom α-MEM 
without sodium 
bicarbonate and 
sodium 
monophosphate1 
Bovine 
Supplements 
10% Fetal Bovine Serum2 5% Fetal Bovine Serum2 
Mineral 
Supplements 
N/A N/A N/A 
2.5 mM sodium 
bicarbonate3, 0.25 
mM sodium 
monophosphate3 
Differentiating 
Supplements 
N/A N/A 1X insulin-transferrin-selenium4 
Other 
Treatments 
N/A N/A 
± 0.2mM L-Ascorbic Acid3, ± 200 
ng/mL BMP-25 
Final [Pi] (mM) 1.0 1.0 1.0 0.25 
1Thermo Fisher Scientific, 2Atlanta Biologicals, 3Sigma-Aldrich, 4Lonza BioWhittaker, 
5R&D Systems  
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Table 2. Cell Culture Experimental Groups. Cell groups varied on phosphate levels, 
BMP-2 levels, and L-Ascorbic Acid levels. 100% Pi: 1.0mM phosphate; 25% Pi: 
0.25mM phosphate; +/-BMP: with and without BMP-2; and +/-AA: with and without L-
Ascorbic Acid 
 
 
2. Intracellular Lipid Droplet Quantification 
At day 8 of cell treatment, respective mediums were removed from the 12 well plates 
and the cells were washed with 1X Dulbecco’s phosphate buffered saline with calcium 
and magnesium (Sigma-Aldrich Inc., Saint Louis, MO). Each well was stained with 
500μL of 1μg/mL Nile Red (Sigma-Aldrich Inc., Saint Louis, MO) and incubated in the 
dark for 15 minutes. The Nile Red stock solution (1mg/mL) was prepared by dilution 
with 1X phosphate buffered saline. After incubation, each well’s excitation was read at 
485 nm and a bandwidth of 20nm. Emission was read at 530nm and a bandwidth of 25 
nm. Both excitation and emission were read using a BioTek Synergy 2 Multi-mode 
Group 
Number 
Phosphate 
Level 
BMP-2 
L-Ascorbic 
Acid 
1 100% Pi +BMP +AA 
2 100% Pi -BMP +AA 
3 25% Pi +BMP +AA 
4 25% Pi -BMP +AA 
5 100% Pi +BMP -AA 
6 100% Pi -BMP -AA 
7 25% Pi +BMP -AA 
8 25% Pi -BMP -AA 
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Microplate Reader (BioTek Instruments Inc., Winooski, VT). Well intracellular lipid 
droplet accumulation was normalized to cell number as approximated by the PicoGreen 
fluorescence assay. 
 
3. Extraction for PicoGreen, BCA, and Hydroxyproline Assays 
After Nile Red Staining, all 12 well cell culture plate cells were washed with 1X 
phosphate buffered saline and were extracted. The extraction buffer consisted of 4M 
Guanidine HCl (Sigma-Aldrich Inc., Saint Louis, MO), 1% Triton X-100 Lysis Buffer 
(Sigma-Aldrich Inc., Saint Louis, MO), and 10mM 1X TE Buffer (pH 7.4) (Life 
Technologies Inc., Beverly, MA). Each well in the 12 well cell culture plates received 
250μL of the extraction buffer. Plates were then placed on a plate shaker for 
approximately 30 minutes. Cell layers were then scraped with a cell scraper and 
transferred to 1.5mL Eppendorf tubes, and 250μL of Ultrapure (RNase- and DNase-free) 
Distilled Water (Thermo Fisher Scientific, Waltham, MA) was added to each sample.  
 
4. RNA Extraction and Quality Analysis 
After removing media from all 6 well cell culture plates, total RNA from each well 
was extracted with 1mL Qiazol Lysis reagent and transferred into 1.5mL Eppendorf 
tubes. RNA was then given 0.2 mL (molecular biology grade) (Chloroform Sigma-
Aldrich Inc., Saint Louis, MO), mixed vigorously, and stored at room temperature for 10 
minutes. The samples were then centrifuged at 12,000g for 15 minutes at 4° C. The 
aqueous phase of RNA was then transferred to a new 1.5mL Eppendorf tube, 0.5mL 
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isopropanol was added to the samples, and the resultant mixture was stored at room 
temperature for 10 minutes. The samples were then again centrifuged at 12,000g for 10 
minutes at 4° C. The supernatant was then removed and each pellet resulting from 
centrifugation was washed with 1mL 75% ethanol (Fisher Scientific, Hampton, NH) and 
vortexed. Samples were then centrifuged at 7,500g for five minutes at 4° C and the 
remaining supernatant was discarded. The RNA pellets that remained were air dried for 
3-5 minutes, resuspended in 20µL Ultrapure Distilled Water, and frozen in a freezer at -
80° C.  
To assure for proper quality and proper extraction of the RNA samples, the samples 
were electrophoresed in a 1% agarose gel supplemented with GelStarTM Nucleic Acid Gel 
Stain (Lonza Rockland, Inc., Rockland, ME). Samples that were degraded or failed to 
show a presence on the gel were rerun on the gel, and if status was unchanged from the 
first gel, the samples were excluded from further analysis. To determine the concentration 
of the RNA samples and to ensure there was no organic or inorganic contamination, 
samples were tested with a NanoDrop ND-1000 Spectrophotometer (NanoDrop 
Technologies, Inc., Wilmington, DE).  
 
5. DNA, Protein, and Hydroxyproline Quantification 
Relative DNA concentration of cells grown in the 12 well plates was quantified using 
a Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fisher Scientific, Waltham, MA) 
according to the manufacturer’s instructions. Excitation was measured at a wavelength of 
485 nm and a bandwidth of 20 nm. Emission was measured at a wavelength of 530 nm 
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and a bandwidth of 25 nm. Both excitation and emission were measured using a BioTek 
Synergy 2 Multi-mode Microplate Reader. Samples were diluted 1:20 in Ultrapure 
Distilled Water prior to addition of the reagent in order to ensure that samples were 
within the proper detection limits.  A standard curve was generated and used to calculate 
DNA concentration in each well based on the PicoGreen intensity. 
Protein concentration of cells grown in the 12 well plates was quantified using a 
MicroBCA protein assay kit (Thermo Fisher Scientific, Waltham, MA). Absorbance was 
read at 562 nm using a BioTek Synergy 2 Multi-mode Microplate Reader. Samples were 
diluted 1:20 in Ultrapure Distilled Water prior to addition of the reagent in order to 
ensure that samples were within the proper detection limits. A standard curve was 
generated and used to calculate absolute protein concentration in each well based on the 
absorbance at 562 nm. Absolute protein concentration of each well was normalized to the 
respective DNA concentration.  
Hydroxyproline content, a measure of collagen content, was quantified from samples 
from 12 well plates using the Hydroxyproline colorimetric assay kit (Sigma-Aldrich, 
Saint Louis, MO). The preparation of samples and the assay were executed according the 
manufacturer’s instructions except with two minor modifications. First, some samples 
contained an insoluble material thought to be cross-linked collagen. The samples were 
centrifuged at 1,400rpm for five minutes to isolate the insoluble material. The resulting 
supernatant containing soluble proteins was added to new 1.5mL Eppendorf tubes. An 
amount of 75 μL of the supernatant containing soluble materials was added to the 
Eppendorf tubes with the insoluble substance. From this point, the entirety of the 
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insoluble substance and 75 μL of the soluble materials were transferred into pressure-
tight vials with PTFE-lined caps. Secondly, instead of adding 100 μL of concentrated 
(~12M) hydrochloric acid to the pressure-tight vials, 75 μL of the hydrochloric acid was 
added to the 75 μL of soluble materials and insoluble substance. After these two minor 
modifications were made in the sample preparation, the rest of the procedure was run 
according to the manufacturer’s instructions. Absorbance was read at 562 nm using a 
BioTek Synergy 2 Multi-mode Microplate Reader. A standard curve was generated and 
used to calculate total hydroxyproline content for each well based on each sample’s 
respective 562 nm absorbance. Total hydroxyproline content for each well was 
normalized to its respective DNA concentration.  
 
6. Reverse Transcription 
After total RNA for each sample was checked for quality and its concentration 
determined, each sample’s RNA was reverse transcribed. Samples were all diluted with 
Ultrapure Distilled Water to 10.4 μL to the same concentration prior to reverse 
transcription. A mix of MgCl2 (6.61 μL), dNTP Mix (6.0 μL), 10X RT buffer (3.0 μL), 
random hexamers (1.5 μL), RNase Inhibitor (0.6 μL), and TaqMan™ Reverse 
Transcriptase (1.89 μL) was added to each sample. The tubes were placed in the 
Eppendorf Mastercycler Personal (Eppendorf®, Hamburg, Germany) with the following 
cycles: 25°C for 10 minutes, 37°C for 60 minutes, and 95°C for five minutes. The 
subsequent complementary DNA (cDNA) were diluted 1:5 and 1:20 with Ultrapure 
Distilled Water and then stored in a -20°C freezer until use for qRT-PCR. 
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7. Quantitative Real-time Polymerase Chain Reaction 
After preparation of cDNA, this reaction was used to amplify DNA primer templates 
for genes of interest (Table 3). In each qRT-PCR reaction, 9 μL of each cDNA sample 
was added to 10 μL TaqMan™ Universal PCR Master Mix (Thermo Fisher, Scientific, 
Waltham, MA) and 1 μL of the primer set. Negative controls in each reaction were 
prepared with 9 μL Ultrapure Distilled Water, 10 μL Universal PCR Master Mix, and 1 
μL of the primer set. After wells were filled, a clear film (Life Technologies Corporation, 
Carlsbad, CA) was applied to the 96 well plate and centrifuged at 1500rpm for 2 minutes 
to remove any bubbles. The qRT-PCR reaction was performed using the 7300 Real time 
PCR System (Applied Biosystems, Foster City, CA) and the qRT-PCR reaction was set 
up as follows: 50°C for two minutes, 95°C for 10 minutes, 95°C for 15 seconds repeated 
40 times, and 60°C for one minute. Each sample was run in triplicate and normalized to 
18s rRNA to correct for variations within the starting amounts of the samples of total 
RNA. Sample threshold cycle (CT) values were normalized to the threshold value for 18s 
for each timepoint (CT = CT(Gene) – CT(18s)). Expression levels were then normalized to 
day 8 control growth media cell RNA for direct comparison between different treatment 
groups (CT = CT(Exp) – CT(Ctrl)). Fold change in expression for the different 
treatment group RNAs were graphed (2-CT, where day 8 control growth media cell 
RNA = 0). 
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Table 3. DNA Primer Templates For qRT-PCR. Primers of genes of interest that were 
added to PCR Master Mix and diluted cDNA samples for qRT-PCR. All primers were 
included with the FAM™ reporter dye. All primers were purchased from Thermo Fisher 
Scientific, Waltham, MA and all primer Assay IDs are listed. Resultant Protein and its 
function are listed. 
Gene Assay ID Protein and Function 
Rn18s Mm04277571_s1 Ribosomal RNA Subunit; 
Housekeeping gene 
Acan Mm00545794_m1 Aggrecan; Cartilage-
specific Proteoglycan 
Col2a1 Mm00491889_m1 
Collagen Type II Alpha 1 
Chain; Component of 
Cartilage 
Col10a1 Mm00487041_m1 
Collagen Type X Alpha 1 
Chain; Secreted by 
Hypertrophic Chondrocytes 
Pparg Mm00440940_m1 
Peroxisome Proliferator 
Activate Receptor Gamma; 
Adipogenesis 
Plin1 Mm00558672_m1 Perilipin 1; Coats Lipid 
Droplets in Adipocytes 
Ucp1 Mm01244861_m1 
Uncoupling Protein 1; 
Thermogenesis in Brown 
Adipose Tissue  
 
 
8. Statistical Analysis 
Mean values and standard deviations were calculated from measured values among 
all of the different media conditions. There was a total of 16 controls for the eight 6 well 
plates and 32 controls for the eight 12 well plates; however, when generating control 
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group averages, only four (4) and three (3) controls were considered for experiments of 
the 6 well and 12 well plates, respectively. Controls were chosen at random using a 
random number generator. Outcomes were compared among the different conditions 
using three-factor analyses of variance (ANOVA) to determine differences due to 
phosphate content, BMP-2 presence, and ascorbic acid presence at a significance of  = 
0.05. Subsequent post-hoc tests were run on significant factors and interactions 
determined by three-factor ANOVA and tested for significance at an  = 0.05.  All 
experiments were run twice to prove reproducibility.  Results from the second run are 
shown here.  
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RESULTS 
 
1. Cell Culture Morphology 
Phase-contrast microscopy examination of C3H10T1/2 stem cells cultured with 
differentiating media conditions were undertaken and cellular morphology was captured 
via photography of cell cultures at 10X magnification (Figure 6). Groups that were 
treated with BMP-2 (BMP) showed early formation and cluster of nodules while groups 
that were not treated with BMP did not show the formation of these nodules. Further 
examination of the 100% Pi +BMP +AA group, its cells, and its nodule morphology were 
undertaken at 20X magnification (Figure 7). Groups in 25% Pi media showed some cells 
that were no longer adherent on their respective cell culture plate indicating cell death, 
which were not present in wells with 100% Pi. Groups of cells in ascorbic acid treated 
media did not look morphologically different from cells not grown in ascorbic acid. In 
groups that were in 25% Pi –BMP +/-AA media, there was noted to be a morphologically 
distinct cell type present with multiple intracellular lipid droplets. Further examination of 
these groups was undertaken at 20X magnification (Figure 7). 
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Figure 6. Cell Morphology Images. Photographs of cell morphology of each of the 
treatment groups was obtained via phase-contrast microscopy at 10X magnification. 
Photographs have their corresponding treatment group label below with differing 
phosphate content, BMP treatment, and ascorbic acid treatment. 100% Pi: 1.0mM 
phosphate; 25% Pi: 0.25mM phosphate; +/-BMP: with and without BMP-2; and +/-AA: 
with and without L-Ascorbic Acid. 
 
 
Figure 7. Further Cellular Morphology Images. Photographs of cell morphology of 
specific treatment groups were obtained via phase-contrast microscopy at 20X 
magnification. Photographs have their corresponding treatment group label below with 
differing phosphate content, BMP treatment, and ascorbic acid treatment. 100% Pi: 
1.0mM phosphate; 25% Pi: 0.25mM phosphate; +/-BMP: with and without BMP-2; and 
+/-AA: with and without L-Ascorbic Acid.  
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2. DNA Content Quantification 
Cellular DNA content was assessed using the PicoGreen fluorescence assay (Figure 
8). There was no significant difference of the amount of DNA in groups that were treated 
with 100% Pi and 25% Pi (p=0.4887). Treatment groups that were not treated with BMP 
had significantly more DNA content than groups that were treated with BMP (p<0.001). 
DNA content in –AA groups were significantly greater than +AA groups (p=0.0197). 
There was a significant interaction between phosphate content and ascorbic acid 
treatment (p=0.0183). Groups in 25% Pi and –AA had significantly more DNA than 
groups in 25% Pi and +AA (p=0.0069).  There was also a significant interaction between 
ascorbic acid treatment and BMP treatment (p=0.0327).  
Figure 8. Cellular DNA Concentration of Groups in Different Media Conditions. 
Cellular DNA content was quantified using the PicoGreen fluorescence assay. DNA 
content was greatest in those groups treated without BMP. Values from 
excitation/emission at 465nm/530nm for each treatment group were normalized to the 
values from control groups. P-values of each factor are listed. 
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3. Intracellular Lipid Droplet Quantification 
Nile Red staining and subsequent excitation recording showed lipid droplet 
accumulations in all treatment groups (Figure 9). Groups treated in 100% Pi developed 
significantly more intracellular lipid droplets than groups in 25% Pi (p<0.001). Groups 
treated with BMP accumulated significantly more intracellular lipid droplets than groups 
that were not treated with BMP (p<0.001). Ascorbic acid-treated groups significantly 
developed more intracellular lipid droplets than –AA groups (p<0.001). There was an 
interaction between BMP treatment, AA treatment, and Pi media content (p<0.001). 
Interestingly, 100% Pi -AA groups that differed in their BMP treatment did not produce a 
significantly different amount of intracellular lipid droplets (p=0.9944).  
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Figure 9. Mean Lipid Content of Groups in Different Media Conditions. Intracellular 
lipid droplet content was quantified using Nile Red staining. Group mean RFU values 
were calculated and normalized to mean RFU of controls and values of DNA content 
obtained from PicoGreen Assay. P-values of each factor are listed. Treatment groups are 
assigned alphabetical letters corresponding to significantly different groups (significant 
interaction Pi*BMP*AA). Groups with different letters are statistically different at a p-
value of <0.0001. If letters are not shown, no significant difference was found for the 
interaction term. 
 
4. Protein Quantification  
Protein accumulation was present in all experimental groups (Figure 10). Phosphate 
content in differentiating media was not significantly different from 100% Pi and 25% Pi 
groups (p=0.1027). Groups that were treated with BMP produced significantly more 
protein than groups that were not treated with BMP (p<0.001). There was no significant 
difference in protein production between +AA and –AA groups (p=0.1433). However, 
there was a significant interaction between phosphate content and ascorbic acid 
supplementation (p=0.0296). With this interaction, the 25% Pi +AA group produced 
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significantly more protein than the 100% Pi +AA group (p=0.0399). There was no 
significant interaction between phosphate content and BMP treatment (p=0.4051) or 
between BMP treatment and ascorbic acid treatment (p=0.6172).  
 
Figure 10. Protein Concentration of Groups in Different Media Conditions. Protein 
concentration was quantified using the MicroBCA Protein Assay Kit. Groups treated with 
BMP produced significantly more protein than groups without BMP. Group average 
protein concentrations were normalized to DNA concentration and control average 
protein concentration. P-values of each factor are listed. 
 
5. Hydroxyproline Quantification 
Hydroxyproline was present in all experimental groups (Figure 11). Hydroxyproline 
production was not influenced by differing phosphate conditions (p=0.2951). BMP 
treatment was not significant on influencing hydroxyproline production (p=0.1485). 
Groups treated with ascorbic acid produced significantly more hydroxyproline than 
groups that were not treated with ascorbic acid (p=0.0035). The interaction between was 
phosphate content and ascorbic acid treatment was not statistically significant 
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(p=0.0744). However, in this trend, groups in 100% Pi +AA media produce more 
hydroxyproline than groups in 100% Pi -AA media (p=0.0106). There was no difference 
in hydroxyproline production between 25% Pi +/-AA groups (p=0.6686).  
 
Figure 11. Hydroxyproline Concentration of Groups in Different Media Conditions. 
Hydroxyproline concentration was quantified using the Hydroxyproline colorimetric 
assay kit. Group average hydroxyproline concentrations were normalized to DNA 
concentration and control group average hydroxyproline concentration. P-values of each 
factor are listed. 
 
6. Gene Expression 
We first evaluated chondrogenic genes that would be expressed in various types of 
chondrocytes during C3H10T1/2 differentiation. The early chondrocyte differentiation 
marker, Col2a1, was expressed in varying levels in cells grown in different media 
conditions (Figure 12A). Phosphate concentration was not a significant factor in Col2a1 
expression in C3H10T1/2 cells (p=0.3898). Groups that were treated with BMP had 
significantly more Col2a1 expression than the groups that were not treated with BMP 
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(p<0.001). Groups that were treated with ascorbic acid had increased Col2a1 expression 
than groups treated without ascorbic acid (p=0.0449). There was a trend of an interaction 
between ascorbic acid treatment and BMP treatment (p=0.0871) as well as a trend of 
interaction between all three variables (p=0.0697), due to insufficient statistical power. 
There was no significant interaction between phosphate and BMP (p=0.1581) or 
phosphate and ascorbic acid (p=0.9772).  
The next gene, Acan, which is a marker of proliferating zone chondrocytes, was 
examined and its expression was assessed (Figure 12B). Acan expression was 
significantly different between varying phosphate concentrations, with groups in 100% Pi 
media expressing more Acan than groups in 25% Pi media (p=0.0009). Cells that were 
treated with BMP expressed significantly more Acan than cells that were not treated with 
BMP (p<0.0001). Groups in +AA differentiating media expressed significantly more 
Acan than group in –AA differentiating media (p<0.0001). There was significant 
interaction between phosphate and ascorbic acid (p=0.0011), phosphate and BMP 
(p=0.0009), and BMP and ascorbic acid (p<0.001).  
Expression of ColXa1, a marker of hypertrophic chondrocytes, is shown (Figure 
12C). There was a trend indicating that cells in 25% Pi expressed more ColXa1 than cells 
in 100% Pi conditions; however, this trend was not statistically significant (p=0.0734). 
C3H10T1/2 cells grown in +BMP differentiating media expressed significantly more 
ColXa1 than those cells grown in –BMP differentiating media (p<0.0001).  Groups that 
were treated with ascorbic acid showed no significantly different expression levels of 
ColXa1 than those groups treated without ascorbic acid (p=0.8852). There was a 
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significant interaction between phosphate and ascorbic acid (p=0.0169), with 25% Pi 
+AA groups expressing more ColXa1 than 100% Pi +AA groups (p=0.0220). There was 
also a significant interaction between all three factors (p=0.0212). There were no 
significant interactions between phosphate content and BMP (p=0.9310) or BMP and 
ascorbic acid (p=0.2043).  
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Figure 12. Gene Expression of Three Chondrocyte Markers. Col2a1 (A), Acan (B), 
and ColXa1 (C) expression levels were plotted for various differentiation medium 
groups. Gene expression was measured using q-RTPCR. Experimental CT values were 
normalized to 18s gene expression and control CT values. P-values of each factor are 
listed. Treatment groups are assigned alphabetical letters corresponding to significantly 
different groups (significant interaction Pi*BMP*AA). Groups with different letters are 
statistically different at a p-value of <0.03. If letters are not shown, no significant 
difference was found for the interaction term.   
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We then evaluated adipogenic genes for both white and brown adipose tissue 
during C3H10T1/2 differentiation (Figure 13). Pparg, a marker of adipogenesis, was 
expressed differently in 100% Pi and 25% Pi conditions, with groups in 25% Pi 
differentiating media expressing significantly more Pparg than 100% Pi differentiating 
media groups (p<0.0001) (Figure 13A). Groups treated with BMP expressed Pparg 
significantly more than groups treated without BMP (p<0.0001). Cells in +AA culture 
media expressed more Pparg than cells in –AA media (p<0.0001). There was significant 
interaction between phosphate and ascorbic acid (p=0.0002). While there was a more 
expression of Pparg in 25% Pi +AA media than both 25% Pi -AA (p<0.0001) and 100% 
Pi +AA (p<0.0001) mediums, there was not a significant difference between the 100% Pi 
+AA group and 100% Pi -AA group. (p=0.0710). Phosphate content and BMP treatment 
had a significant interaction (p<0.0001) as well as ascorbic acid treatment and BMP 
treatment (p=0.0002).  
Expression levels of Plin1, a marker of mature adipocytes with large unilocular 
lipid droplets, are shown in Figure 13B. Cells in culture media with 25% Pi expressed 
significantly more Plin1 than cells in media with 100% Pi (p<0.0001). While there was a 
trend of –BMP groups expressing more Plin1 than +BMP groups, this trend was not 
significant (p=0.0755). Even though BMP treatment alone was not significant, there was 
a significant interaction between BMP and phosphate content (p=0.0120). Specifically, 
cells in 100% Pi +BMP media expressed significantly less Plin1 than cells in 100% Pi –
BMP media (p=0.0134) while cells in 25% Pi +/-BMP mediums were not significantly 
different from each other (p=0.9301). Groups treated with ascorbic acid significantly 
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expressed more Plin1 than groups that were not treated with ascorbic acid (p<0.0001). 
Ascorbic acid treatment and BMP treatment also exhibited a significant interaction 
(p=0.002).   
Ucp1, a marker of brown adipose tissue differentiation as well as energy 
uncoupling in the electron transport chain, was also evaluated (Figure 13C). The overall 
statistical model was not statistically significant (p=0.1106). 
The model effects for all terms in the statistical models are summarized for all 
measured outcomes in Table 4. 
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Figure 13. Gene Expression of Three Adipocyte Markers. Pparg (A), Plin1 (B), and 
Ucp1 (C) expression levels were plotted for various differentiation medium groups. Gene 
expression was measured using q-RTPCR. Experimental CT values were normalized to 
18s gene expression and control CT values. P-values of each factor are listed. Treatment 
groups are assigned alphabetical letters corresponding to significantly different groups 
(significant interaction Pi*BMP*AA). Groups with different letters are statistically 
different at a p-value of <0.03. If letters are not shown, no significant difference was 
found for the interaction term. 
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7. Statistics Summary 
Table 4. Summary of Significant Factors in Different Experimental Tests. All 10 
experiments were run and statistical analysis was completed. X: terms with a p-value 
≤0.05; *: terms with 0.05 < p ≤ 0.085); and n.s.: terms with a p-value > 0.085 
Test Pi BMP AA BMP*Pi BMP*AA Pi*AA BMP*Pi*AA 
DNA n.s. X X n.s. X X n.s. 
Nile Red X X X X X X X 
Protein n.s. X n.s. n.s. n.s. X n.s. 
Hydroxyproline n.s. n.s. X n.s. n.s. * n.s. 
Col2a1 n.s. X X n.s. n.s. n.s. * 
Acan X X X X X X X 
ColXa1 * X n.s. n.s. n.s. X X 
Pparg X X X X X X X 
Plin1 X * X X X X X 
Ucp1 n.s. n.s. n.s. n.s. n.s. n.s. n.s. 
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DISCUSSION 
This study investigated the relationships between bone morphogenetic protein-2 mediated 
stem cell chondrogenic differentiation dietary phosphate, and promotion of collagen 
hydroxylation via ascorbate on cell growth, protein production and differentiated 
function.  The goals of this study were to focus on protein and hydroxyproline production 
during mesenchymal stem cell differentiation as well as cellular commitment and 
differentiation of MSCs. Examination of these processes was examined by culturing 
C3H10T1/2 murine stem cells in eight differentiation mediums, containing different 
phosphate concentration (100% Pi or 25% Pi), BMP-2 treatment (+/-BMP), and ascorbic 
acid supplementation (+/-AA).  
 
1. Protein and Hydroxyproline Production 
Differentiating MSCs accumulated protein during the eight days of cell culture, 
which is consistent with the production of extracellular matrix (ECM) proteins and 
collagens during chondrogenesis. Cells that were cultured without BMP produced 
significantly less protein than cells that were cultured with BMP. This indicates that 
either MSC differentiation into chondrocytes or normal transcription factor regulation 
relevant to ECM proteins, or both, are impaired by the lack of BMP. These findings are 
consistent with previous findings that in induced BMP2/4 knockout osteoblasts in mice 
have decreased expression of genes related to ECM formation (Wu et al. 2016). The 
BMP2/4 induced-knockout osteoblasts are already committed while the C3H10T1/2 cells 
are multi-potential in nature; however, similar BMP-2 signaling in the multi-potential 
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cells could explain the decrease in normal protein production seen. While increased 
protein production fueled by BMP could be merely a side effect of cellular differentiation 
of MSCs into chondrocytes, further analysis of BMP’s signaling and its intersection with 
protein-related transcription factors or growth factors could provide novel mechanisms to 
BMP’s promotion of different proteins  
Notably, in this study, protein production depended on an interaction between 
phosphate and ascorbic acid; with 25% Pi +AA cells producing more protein than 100% 
Pi +AA cells. This is in agreement with a previous study of ATDC chondro-progenitors, 
which saw that cells grown in diminished inorganic phosphate conditions and ascorbic 
acid produced more protein (Blank 2016). However, there was no difference between 
25% Pi -AA groups and 100% Pi -AA groups however.  
Differentiating MSCs also produced hydroxyproline throughout the eight days of 
culture. Hydroxyproline production was dependent on normal ascorbic acid levels. In the 
case of scurvy, a condition caused by a deficiency of ascorbic acid, hydroxyproline 
production and integrity are decreased. While proline is being produced, the 
hydroxylation of proline is not able to be achieved due to the lack of ascorbic acid, a 
necessary co-factor of prolyl-4-hydroxylase. Initially, we expected that phosphate 
deficiency might play a role on hydroxyproline production. In previous studies looking at 
mice fed phosphate-deficient diets, transcriptomic analysis of fracture calluses showed a 
downregulation of 4-prolyl-hydroxylase, the enzyme that hydroxylates proline to produce 
hydroxyproline (Carroll 2016). In this study, though, we did not find any differences in 
hydroxyproline production due to phosphate content. This could be due to a lack of 
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power in our statistical analysis and lack of samples tested in this assay. In our 
assessment on hydroxyproline production, however, we found a trend in the interaction 
between ascorbic acid treatment and phosphate concentration. In this trend, there was a 
difference in 100% Pi +/-AA groups but not a difference in 25% Pi +/-AA groups.  
 
2. Cellular Differentiation and Cell Lineage Commitment 
When analyzing gene expression of differentiating C3H10T1/2 cells, it was seen that 
normal differentiation of these cells into the chondrocyte lineage was dependent on BMP 
as this was a significant factor in the expression of both Col2a1 and Acan, early and 
proliferative chondrocyte markers. In parallel with increased chondrocyte differentiation 
due to BMP, there was seen to be a decrease in cell number in +BMP cell cultures, as 
indicated by decreased cellular DNA content. This suggests that BMP not only induces 
cell differentiation in the C3H10T1/2 cells, but also halts proliferation of these cells or 
induces cell death of non-differentiated cells as a means of preserving energy and 
resources to those stem cells undergoing cellular differentiation, an energy intensive 
process (Shum et al. 2016). BMP was also necessary for progression of MSCs to further 
differentiate into hypertrophic chondrocytes, as seen in the significant difference of 
ColXa1 expression in +/-BMP groups. These findings highlighting the importance of 
BMP in chondrocyte differentiation are in agreement with a study of BMP knockout mice 
which showed that a lack of BMP led to defects of chondrocyte proliferation in growth 
centers as well as improper chondrocyte maturation (Shu et al. 2011).  
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While a lack of BMP in 100% Pi +AA conditions led to increased expression of 
Pparg, an adipogenesis marker, there was also an increase of Pparg expression in 25% Pi 
+AA conditions when there was BMP treated to the cells. In fact, the level of relative 
expression in this low-phosphate media was significantly greater than the 100% Pi –BMP 
+AA group. Thus, phosphate may have a role in shifting cell lineage commitment to the 
adipocyte lineage through BMP signaling resistance. Similar conclusions were reached 
with the Plin1 gene, which showed a difference between 100% Pi +/-BMP +AA groups 
with the –BMP group showing higher Plin1 expression, but no difference in expression 
between 25% Pi +/-BMP +AA groups.  
This observation of BMP resistance was seen in two in vivo studies of mice that 
were given phosphate-deficient diets. Fracture calluses appeared to have more adipocyte 
cells present compared to mice given normal phosphate diets (Ko et al. 2016; Wigner et 
al. 2010). Further analysis by one of the groups showed that immediate downstream 
signaling from BMP was, in fact, impaired in in vitro analysis (Wigner et al. 2010). Our 
results of relative expression of these two adipocyte genes strengthen the observations 
and inferences proposed by these the two studies.  
Not only does low phosphate conditions play a role in cell lineage commitment by 
affecting BMP signaling, but also our gene expression analyses of Plin1 and Pparg 
indicate that low phosphate conditions alone are significant in leading to increased 
differentiation of undifferentiated C3H10T1/2 cells into the adipocyte cell lineage. There 
was also some indication that differences in phosphate content altered ColXa1 
expression, a marker of hypertrophic chondrocytes. While not statistically significant, 
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there was a trend that showed 25% Pi groups expressed more ColXa1 than 100% Pi 
groups. This could infer that either cells in phosphate deficient media are progressing 
faster through the different stages of chondrocyte maturation or that the phosphate 
deficient media is not allowing hypertrophic chondrocytes to terminally differentiate. It 
does not seem that phosphate deficiency is contributing to faster maturation of early 
chondrocytes to hypertrophic chondrocytes as phosphate deficiency also hindered the 
progression of early chondrocytes into proliferating zone chondrocytes as evidenced by 
Acan gene expression results. Not only that but Liu et al. has also shown that phosphate 
restriction hinders the differentiation of proliferative chondrocytes into hypertrophic 
chondrocytes (Liu et al. 2014). Most likely, the low phosphate conditions are impairing 
hypertrophic chondrocytes from undergoing apoptosis and terminally differentiating, 
leading them to continually produce type X collagen as well as other ECM proteins. This 
conclusion is strengthened by past studies, which have shown that hypertrophic 
chondrocyte-specific caspase-mediated apoptosis in the growth plate is impaired by 
phosphate via lack of activation of mitochondrial permeability (Sabbagh, Carpenter, and 
Demay 2005). Interestingly, the halting of hypertrophic chondrocyte apoptosis leading to 
increased matrix production in these cells could explain the increased protein production 
observed in low phosphate conditions. Further analysis of specific protein products 
formed by hypertrophic chondrocytes and analyzing these products as fraction of total 
protein in cell culture could reveal if the inhibition of hypertrophic chondrocyte apoptosis 
from phosphate deficient conditions is in fact the underlying explanation for this increase 
protein found in cell culture.      
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3. Limitations and Future Directions 
There were multiple limitations in conducting this research study including sample 
size and mimicking conditions of cells in fracture calluses and growth plates. First, our 
extractions of DNA and protein products did not seem to provide us with enough material 
to analyze multiple runs of specific biochemical assays. Quantification of hydroxyproline 
was a sample intensive assay which used up most of the sample extraction. Ways to 
correct this in the future are to have a more balanced plate design, assigning more 
experimental differentiation medium groups than control growth medium groups. 
Distinction of qRT-PCR values between cell culture replication could be improved by 
insuring that several samples were included in every run to assess for batch differences. 
Also, statistical analysis for some parameters, especially the multifactor ANOVA 
analysis of hydroxyproline, did not have sufficient power to assess the role of phosphate, 
BMP-2, and ascorbic acid.  
Cell culture experiments lacked some elements that may be present when conducting 
in vivo experiments. With regards to fracture healing studies, cell culture experiments do 
not accurately account for hypoxic conditions that are seen in bone. Also, general 
stability of cell culture plates could be significantly different from the stability seen in 
fractured bone environments. Cell culture experiments are useful resources to study 
multifactorial experiments, but there are some limitations and confounding factors that 
have yet to be elucidated and that cannot be accounted for in this cell culture model. 
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Eventual validation of hypothesis and findings using in vivo experiments will be 
necessary. All together, these limitations could explain some of the differences that were 
seen between our hypotheses and our results as well as between past in vivo studies and 
our results.  
Further experimentation using updated procedures and controlled methods can help 
bring validity to our results while also possibly uncovering new significant findings. Not 
only this, but future runs of the C3H10T1/2 cells might also provide some significant 
findings that are currently seen to be trends but are not statistically significant. Inclusion 
of energetic analysis of these C3H10T1/2 via the Seahorse XF96 Extracellular Flux 
Mitochondrial Stress Test would help us to make connections between cellular 
differentiation and energy utilization while also aiding us in the identification of energy 
intensive processes that may be occurring during MSC differentiation as a model of 
endochondral fracture repair.   
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CONCLUSION 
 
In this study, we investigated the effect that phosphate, BMP-2, and ascorbic acid 
availability have on multi-potential cell differentiation and cell lineage commitment as 
well as protein and hydroxyproline production. Our findings highlight importance of 
BMP-2 in the differentiation of multi-potential C3H10T1/2 cells. We also further identify 
phosphate’s role in C3H10T1/2 cell lineage commitment and its role in the disruption of 
BMP-2 mediated differentiation, expanding on past in vivo and in vitro studies. This 
study also furthers past work conducted on chondro-progenitor differentiation and 
provides a clearer picture of fracture healing, from the earliest moment of stem cell 
recruitment. Understanding the early moments after a fracture and the complex processes 
that mediate a bone’s repair are imperative to creating diagnostic tools to detect delayed 
healing in an early fracture and improving treatment outcomes in patients with aberrant 
fracture healing. 
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